p53 wild-type
Showing 1 - 25 of >10,000
Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)
Recruiting
- Endometrial Cancer
- Selinexor
- Matching Placebo for selinexor
-
Miami Beach, Florida
- +6 more
Jan 31, 2023
Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)
Recruiting
- Malignant Salivary Gland Cancer
- Salivary Gland Cancer
-
Tampa, Florida
- +2 more
Feb 10, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (drug, other, biological)
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Bortezomib
- +4 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 5, 2022
Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)
Not yet recruiting
- Pancreatic Neoplasms
- +2 more
- BI 907828
- (no location specified)
Aug 22, 2022
Metastatic Colon Cancer Trial in Italy (Trifluridine Tipiracil, Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX])
Completed
- Metastatic Colon Cancer
- Trifluridine Tipiracil
- Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX]
-
Monserrato, CA, Italy
- +7 more
Jul 21, 2022
NSCLC Trial in China (JAB 21822)
Recruiting
- Non-small Cell Lung Cancer
- JAB 21822
-
Beijing, Beijing, China
- +20 more
Sep 26, 2022
P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)
Recruiting
- P53 Mutation
- +3 more
- Decitabine
- Arsenic Trioxide
-
Shanghai, Shanghai, ChinaHematological department, Shanghai Institute of Hematology, Ruij
Apr 20, 2021
Polyneuropathy, Amyloidosis Trial in Jette (ECG + echocardiography, Answering questionnaires)
Recruiting
- Polyneuropathy
- Amyloidosis
- ECG + echocardiography
- Answering questionnaires
-
Jette, Belgium Capital City, BelgiumUZ Brussel
Jul 14, 2023
Advanced Solid and Hematological TP53wt Tumors Trial in Worldwide (HDM201, ancillary treatment)
Completed
- Advanced Solid and Hematological TP53wt Tumors
- HDM201
- ancillary treatment
-
Boston, Massachusetts
- +14 more
May 20, 2021
Resectable Soft Tissue Sarcoma, Soft Tissue Sarcoma Trial in United States (Navtemadlin, Radiation Therapy)
Recruiting
- Resectable Soft Tissue Sarcoma
- Soft Tissue Sarcoma
- Navtemadlin
- Radiation Therapy
-
Goodyear, Arizona
- +52 more
Jul 21, 2022
Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)
Not yet recruiting
- Pediatric Cancer
- +2 more
- Arsenic trioxide
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023
Advanced BRAFV600 Wild-type Melanoma Trial in Worldwide (Cobimetinib, Atezolizumab, Pembrolizumab)
Terminated
- Advanced BRAFV600 Wild-type Melanoma
- Cobimetinib
- +2 more
-
Tucson, Arizona
- +120 more
Aug 24, 2022
Colon Cancer, Colorectal Cancer, Rectal Cancer Trial in Worldwide (Panitumumab, Bevacizumab, mFOLFOX6)
Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7 Trial in United States (biological, drug, other)
Completed
- Colorectal Adenocarcinoma
- +4 more
- Bevacizumab
- +4 more
-
Scottsdale, Arizona
- +12 more
Jan 27, 2022
Vectibix With Chemotherapy for Metastatic Colorectal Cancer
Completed
- Wild-type RAS Metastatic Colorectal Cancer
- Panitumumab + Chemotherapy
- (no location specified)
Nov 4, 2022
SNPs in p53 and p53 Response Elements on Inflammatory Response
Completed
- HIV-1 Seropositive
- +3 more
-
Research Triangle Park, North CarolinaNIEHS Clinical Research Unit (CRU)
Jan 21, 2023
Unusual Infiltrative Patterns of Malignant Cells in Endometrial
Not yet recruiting
- Endometrial Cancer
- (no location specified)
Mar 11, 2023
Melanoma (Skin) Trial in Baltimore (pentamidine)
Terminated
- Melanoma (Skin)
-
Baltimore, MarylandGreenebaum Cancer Center at University of Maryland Medical Cente
Aug 14, 2019